A new University of Cincinnati Cancer Center study has identified a particular strand of microRNA as a promising new target ...
A new University of Cincinnati Cancer Center study has identified a particular strand of microRNA as a promising new target for overcoming breast cancer treatment resistance and improving outcomes.
A recent study published on December 19, 2024, in the ExRNA journal highlights research from the Novosibirsk Institute of ...
A recent study published on December 19, 2024, in the ExRNA journal highlights research from the Novosibirsk Institute of ...
UC researchers reveal that miR-205 regulates MED1 and HER3, proteins driving breast cancer treatment resistance. Boosting miR ...
ErlySign’s innovation is a biomarker-based test kit capable of detecting oral precancerous conditions within just 15 minutes ...
Mirxes, a leading Singapore-based cancer detection firm, has secured $40 million in financing from CBC Group's R-Bridge Fund to enhance its innovative miRNA technology platform. The investment aims to ...